PLIN2 and focal segmental glomerulosclerosis: In conclusion, our study demonstrates that presumably CPF-containing plasma from FSGS patients alters podocyte lipid metabolism and, in particular, increases expression of the lipid droplet-associated protein perilipin-2 and induces lipid droplet accumulation, which identifies perilipin-2 as a potential biomarker for the presence of CPFs.